achillion pharmaceuticals
(ACHN:NASDAQ GS)
As of 4:30 PM 05/22/13 All times are local (Market data is delayed by at least 15 minutes).
Insiders at achillion pharmaceuticals (ACHN)
| Name (Connections) | Board Relationships | Title | Type of Board Member | Age |
| Michael Kishbauch | 8 Relationships | Chief Executive Officer, President and Director | -- | 63 |
Other Board Members on Board*
| Name (Connections) | Board Relationships | Type of Board Member | Primary Company | Age |
| David Scheer | 44 Relationships | -- | Tengion, Inc. | 59 |
| Robert Van Nostrand BS | 23 Relationships | -- | Achillion Pharmaceuticals, Inc. | 55 |
| Gary Frashier M.B.A., P.E. | 26 Relationships | -- | American Stem Cell, Inc. | 75 |
| Jason Fisherman M.D., MBA | 61 Relationships | -- | Synthesis Capital | 55 |
| David Wright | 25 Relationships | -- | Achillion Pharmaceuticals, Inc. | 64 |
| Dennis Liotta Ph.D. | 57 Relationships | -- | Altiris Therapeutics, Inc. | 64 |
| Nicole Vitullo M.B.A. | 62 Relationships | -- | Domain Associates, L.L.C. | 55 |
| Kurt Graves | 52 Relationships | -- | Intarcia Therapeutics, Inc. | 44 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| ACHN:US | $7.74 USD | -0.01 |  |
| Company | Last | Change |
| Bavarian Nordic A/S | kr68.50 DKK | -0.50 |
| Bristol-Myers Squibb Co | $46.40 USD | +2.34 |
| Emergent Biosolutions Inc | $14.25 USD | +0.04 |
| Gilead Sciences Inc | $55.93 USD | -0.54 |
| Vertex Pharmaceuticals Inc | $78.43 USD | -1.04 |
| View Industry Companies | ||
Industry Analysis
ACHN
Industry Average
| Valuation | ACHN | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 5,492.9x |
|
| Price/Book | 3.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 4,944.1x |
|
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ACHILLION PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
